Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 7
292
Views
2
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Utility of hairless rats as a model for predicting transdermal pharmacokinetics in humans

, , , , , & show all
Pages 831-838 | Received 20 Oct 2019, Accepted 06 Dec 2019, Published online: 17 Dec 2019

References

  • Bartek MJ, LaBudde JA, Maibach HI. (1972). Skin permeability in vivo: comparison in rat, rabbit, pig and man. J Invest Dermatol 58:114–23.
  • Benowitz NL, Jacob P, 3rd, Denaro C, Jenkins R. (1991). Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 49:270–7.
  • Drug Interview Form, Bisono® Tape 8mg. (2013a). Pharmaceuticals and medical devices agency. Available from: http://www.info.pmda.go.jp/.
  • Drug Interview Form, EMLA® CREAM. (2013b). Pharmaceuticals and medical devices agency. Available from: http://www.info.pmda.go.jp/.
  • Drug Interview Form, RIVASTACH® Patch 18mg. (2011) and medical devices agency. Pharmaceuticals . Available from: http://www.info.pmda.go.jp/.
  • Drug Interview Form, Voltaren® Tape 30 mg. (2008). Pharmaceuticals and medical devices agency. Available from: http://www.info.pmda.go.jp/.
  • Horita D, Todo H, Sugibayashi K. (2014a). Analysis of the pretreatment effect of ethanol on the stratum corneum- and hair follicular-penetration of drugs using the hair follicle-plugging method. Chem Pharm Bull 62:578–85.
  • Horita D, Yoshimoto M, Todo H, Sugibayashi K. (2014b). Analysis of hair follicle penetration of lidocaine and fluorescein isothiocyanate-dextran 4 kDa using hair follicle-plugging method. Drug Dev Ind Pharm 40:345–51.
  • Hossain M, Jhee SS, Shiovitz T, McDonald C, et al. (2002). Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer’s type. Clin Pharmacokinet 41:225–34.
  • Ishii Y, Tsutsui S, Doi K, Itagaki S. (1997). Hair follicles of young Wistar strain hairless rats: a histological study. J Anat 191: 99–106.
  • Itagaki SI, Ishii Y, Lee MJ, Doi K. (1995). Dermal histology of hairless rat derived from Wistar strain. Exp Anim 44:279–84.
  • Iwamoto S, Doi C, Uetsuka K, et al. (1998a). Lectin histochemistry of dorsal skin of Wistar-derived hypotrichotic WBN/Ila-Ht rats. Exp Anim 47:183–7.
  • Iwamoto S, Nakayama H, Doi K. (1998b). Morphological and morphometrical study on the dorsal skin of Wistar and WBN/ILA-Ht rats in their developing stage. Evaluation of the proliferation and apoptotic processes. Histol Histopathol 13:981–8.
  • Jung EC, Maibach HI. (2015). Animal models for percutaneous absorption. J Appl Toxicol 35:1–10.
  • Lauer AC, Elder JT, Weiner ND. (1997). Evaluation of the hairless rat as a model for in vivo percutaneous absorption. J Pharm Sci 86:13–8.
  • Leopold G, Pabst J, Ungethüm W, Bühring KU. (1986). Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. J Clin Pharmacol 26:616–21.
  • Liu X, Grice JE, Lademann J, et al. (2011). Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br J Clin Pharmacol 72:768–74.
  • Miyajima A, Kigure A, Anata T, Hirota T. (2015). Mechanism for transport of ivermectin to the stratum corneum in rats. Drug Metab Pharmacokinet 30:385–90.
  • Morimoto Y, Hatanaka T, Sugibayashi K, Omiya H. (1992). Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 44:634–9.
  • Olkkola KT, Isohanni MH, Hamunen K, Neuvonen PJ. (2005). The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. Anesth Analg 100:1352–6.
  • Otberg N, Patzelt A, Rasulev U, et al. (2008). The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 65:488–92.
  • Qvist MH, Hoeck U, Kreilgaard B, et al. (2000). Evaluation of Gottingen minipig skin for transdermal in vitro permeation studies. Eur J Pharm Sci 11:59–68.
  • Radermacher J, Jentsch D, Scholl MA, et al. (1991). Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31:537–41.
  • Sato K, Sugibayashi K, Morimoto Y. (1991). Species differences in percutaneous absorption of nicorandil. J Pharm Sci 80:104–7.
  • Simon GA, Maibach HI. (1998). Relevance of hairless mouse as an experimental model of percutaneous penetration in man. Skin Pharmacol Appl Skin Physiol 11:80–6.
  • Todo H. (2017). Transdermal permeation of drugs in various animal species. Pharmaceutics 9:pii: E33.
  • Urae A. (1994). Comparative bioavailability study of Ba37I42 (nicotine TTS) after a single application to different skin sites in Japanese smokers. J Clin Therap Med 10:53–62.
  • Willis JV, Kendall MJ, Flinn RM, et al. (1979). The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 16:405–10.
  • Yamamoto S, Karashima M, Arai Y, et al. (2017a). Prediction of human pharmacokinetic profile after transdermal drug application using excised human skin. J Pharm Sci 106:2787–94.
  • Yamamoto S, Karashima M, Sano N, et al. (2017b). Utility of Gottingen minipigs for prediction of human pharmacokinetic profiles after dermal drug application. Pharm Res 34:2415–24.
  • Yokota H. (1992). Safety and pharmacokinetic study of L-740. Clin Rep 26:4711–22.
  • Yoshimatsu H, Ishii K, Konno Y, et al. (2017). Prediction of human percutaneous absorption from in vitro and in vivo animal experiments. Int J Pharm 534:348–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.